Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its ...

Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical ...

The transaction between Thermo Fisher and Sanofi is scheduled for completion in Q2 2025, subject to standard closing ...

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product ...

Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product ...

Thermo Fisher is acquiring Sanofi’s Ridgefield, NJ sterile drug plant, transferring 200 employees to bolster U.S. fill‑finish ...

Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...

Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing expectations.

Thermo Fisher Scientific (NYSE:TMO) stock gains as company beats Q2 2025 forecasts with $10.9B revenue, driven by Life ...

Under the expanded partnership, Thermo Fisher will acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, N.J. The science-services and instruments provider said Wednesday that it ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

Two major names in the biopharma industry are announcing a new deal to boost drug product manufacturing in the U.S.